Amyris Overview
- Founded
- 2003
- Status
- Public
- Employees
- 595
- Stock Symbol
- AMRS
- Investments
- 11
- Share Price
- $14.36
- (As of Monday Closing)
Amyris General Information
Description
Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States. The company generates revenue from the sale of renewable products, licenses of and royalties from intellectual property, and grants, and collaborative research and development services.
Contact Information
Website
www.amyris.com
Formerly Known As
Amyris Biotechnologies
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
- 5885 Hollis Street
- Suite 100
- Emeryville, CA 94608
- United States
+1 (510) 000-0000
Amyris Timeline
Amyris Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $14.36 | $14.56 | $1.88 - $23.42 | $4.15B | 289M | 4.77M | -$1.88 |
Amyris Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2020 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
|---|---|---|---|---|
| EV | 1,638,887 | 1,638,887 | 552,997 | 398,688 |
| Revenue | 173,137 | 173,137 | 152,557 | 63,604 |
| EBITDA | (263,773) | (263,773) | (166,295) | (182,611) |
| Net Income | (331,039) | (331,039) | (242,767) | (230,235) |
| Total Assets | 222,814 | 222,814 | 160,966 | 127,925 |
| Total Debt | 282,187 | 282,187 | 289,065 | 209,892 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Amyris Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Amyris‘s full profile, request access.
Request a free trialAmyris Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore Amyris‘s full profile, request access.
Request a free trialAmyris Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of product
Biotechnology
Emeryville, CA
595
As of 2020
00.000
000000000
00.000
00000000
enderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupi
0000000000000
Bagsvaerd, Denmark
0000
As of 0000
00000000
0000000
velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000000000000
Redwood City, CA
000
As of 0000
00000
000000 - 000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAmyris Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novozymes | Corporation | Bagsvaerd, Denmark | 0000 | 00000000 | ||
| 0000000 | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 000000 - 000 | 00000 |
| 0000000 | Corporation | Roslin, United Kingdom | 0 | 0000000000 | ||
| 0000000 | Venture Capital-Backed | Gainesville, FL | 0 | 000.00 | 0000000000 0 | 000.00 |
| 00000000000 000000 | Venture Capital-Backed | Vancouver, Canada | 00 | 000.00 | 0000000000 | 000.00 |
Amyris Executive Team (32)
Amyris Board Members (21)
| Name | Representing | Role | Since |
|---|---|---|---|
| Carole Piwnica JD | Self | Board Member | 000 0000 |
| Frank Kung Ph.D | Self | Board Member | 000 0000 |
| Geoffrey Duyk Ph.D | Self | Board Member | 000 0000 |
| James McCann | Self | Board Member | 000 0000 |
| John Melo | Amyris | President, Chief Executive Officer & Board Member | 000 0000 |
Amyris Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAmyris Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Amyris‘s full profile, request access.
Request a free trialAmyris Investments & Acquisitions (11)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 0000 000000 | 14-Apr-2021 | 000000000000000000 | 00000 | Application Software | 0000 0000 |
| 0000 000000 000000 | 16-Mar-2021 | 00000 0000000 | Food Products | ||
| 00000 000000 | 01-Mar-2021 | 000000000000000000 | Personal Products | 0000 0000 | |
| 000000000 | 26-Jan-2021 | 000000000000000000 | Other Pharmaceuticals and Biotechnology | ||
| Terasana Beauty Company | 22-Jan-2021 | Merger/Acquisition | Personal Products | 0000 0000 |
Amyris Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000000 | Other Pharmaceuticals and Biotechnology | Columbus, OH | 0000 |